Cardiology

Experimental anti-cholesterol drug shows promise

People taking an experimental drug called Repatha (evolocumab) for high cholesterol were half as likely to die or suffer a heart attack or stroke as those taking conventional statins, researchers said Sunday.

Cardiology

Study lifts cloud over heart drugs Zetia, Vytorin

A major study lifts a cloud around Zetia and Vytorin, blockbuster drugs for lowering cholesterol. The study found that these pills modestly lower the risk of heart attacks and other problems in people at high risk for them—evidence ...

Cardiology

Alternative treatment for cholesterol shows promise

An experimental treatment has shown promise in lowering bad cholesterol, offering hope for people at risk of heart disease but who cannot tolerate drugs known as statins, researchers said Sunday.

page 9 from 22